CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • STVN Dashboard
  • Filings
  • Transcripts
  • ETFs
  • Institutional
  • Shorts
  • News
  • Reddit

Stevanato Group Spa (STVN)

Company Profile
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.

Company profile

Ticker
STVN
Exchange
NYSE
Website
www.stevanatogroup.com
CEO
Franco Moro
Employees
Location
Italy
Sector
Manufacturing > Glass Container Manufacturing
Industry (SIC)
Glass Containers
O-I Glass ...
SEC CIK
0001849853
Corporate docs
Underwriting Agreements
Plans of Reorganization
Indentures
Material Contracts & Credit Agreements
Subsidiaries Lists

STVN stock data

Analyst ratings and price targets

Last 3 months
Morgan Stanley
Maintains
Overweight
$22.00
6 Jan 23
Latest filings (excl ownership)
View all
6-K
Current report (foreign)
10 Nov 22
6-K
Current report (foreign)
8 Nov 22
6-K
Current report (foreign)
8 Nov 22
6-K
Stevanato Group Reports Third Quarter 2022 Financial Results
8 Nov 22
6-K
Current report (foreign)
8 Aug 22
6-K
Current report (foreign)
4 Aug 22
6-K
Current report (foreign)
4 Aug 22
6-K
Stevanato Group Reports Second Quarter 2022 Financial Results
4 Aug 22
6-K
Stevanato Group Announces Voting Results from its Annual General Meeting
2 Jun 22
6-K
Stevanato Earnings Call
13 May 22
Transcripts
STVN
Earnings call transcript
2022 Q2
6 Aug 22
STVN
Earnings call transcript
2021 Q4
8 Mar 22
STVN
Earnings call transcript
2021 Q2
19 Aug 21
Latest ownership filings
View all
SC 13G/A
Conestoga Capital Advisors, LLC
19 Jan 23
SC 13G
Copeland Capital Management, LLC
13 Jan 23
SC 13G/A
FMR LLC
12 Dec 22
SC 13G
Conestoga Capital Advisors, LLC
29 Sep 22
SC 13G/A
AMERIPRISE FINANCIAL INC
10 Aug 22
SC 13G
Stevanato Holding S.r.l.
15 Feb 22
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 22
SC 13G/A
LAZARD ASSET MANAGEMENT LLC
10 Feb 22
SC 13G/A
WCM INVESTMENT MANAGEMENT, LLC
10 Feb 22
SC 13G/A
FMR LLC
9 Feb 22

Institutional ownership, Q3 2022

STVN institutional ownership history Ownership history
89.1% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 82 70 +17.1%
Opened positions 22 16 +37.5%
Closed positions 10 15 -33.3%
Increased positions 27 28 -3.6%
Reduced positions 25 20 +25.0%
13F shares Current Prev Q Change
Total value 5.73 bn 5.67 bn +1.0%
Total shares 263.23 mm 261.97 mm +0.5%
Total puts 0.00 0.00
Total calls 0.00 0.00
Total put/call ratio – – –
Largest owners Shares Value Change
Stevanato Holding S.r.l. 230.60 mm $5.18 bn 0.0%
Lazard Asset Management 4.72 mm $79.89 mm -13.2%
FMR 4.06 mm $68.74 mm 0.0%
Conestoga Capital Advisors 3.47 mm $58.84 mm +94.8%
AMP Ameriprise Financial 2.05 mm $34.85 mm -34.4%
ArrowMark Colorado 2.05 mm $34.72 mm +49.1%
Copeland Capital Management 1.41 mm $23.94 mm NEW
Clearbridge Advisors 1.40 mm $23.77 mm +0.4%
GS Goldman Sachs 1.22 mm $20.75 mm -3.2%
WCM Investment Management 1.16 mm $20.28 mm -20.7%
Largest transactions Shares Bought/sold Change
Conestoga Capital Advisors 3.47 mm +1.69 mm +94.8%
Copeland Capital Management 1.41 mm +1.41 mm NEW
AMP Ameriprise Financial 2.05 mm -1.08 mm -34.4%
Magnetar Financial 0.00 -847.44 k EXIT
Lazard Asset Management 4.72 mm -715.76 k -13.2%
ArrowMark Colorado 2.05 mm +675.22 k +49.1%
Royce & Associates 385.54 k -463.42 k -54.6%
Dynamo Internacional Gestao De Recursos Ltda. 341.79 k +341.79 k NEW
WCM Investment Management 1.16 mm -302.93 k -20.7%
Pembroke Management 301.34 k +301.34 k NEW
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro
Stevanato Group Collaborates With Transcoject To Provide Pre-Fillable Syringe Polymer Options For Pharma
24 Jan 23
Leading drug containment provider to release a unique offering including both COP and COC pre-fillable syringes (PFS), adding to its existing glass PFS portfolio, providing customers with the broadest choice for
Morgan Stanley Maintains Overweight on Stevanato Group, Lowers Price Target to $22
6 Jan 23
Morgan Stanley analyst Drew Ranieri maintains Stevanato Group (NYSE:STVN) with a Overweight and lowers the price target from $23 to $22.
Finsight
Resources
  • Knowledgebase
  • Log In
  • Register
Company
  • About
  • Contact
  • Solutions
Products
  • Deal Roadshow
  • DealVDR
  • Evercall
  • Finsight.com
CapEdge
  • Earnings Calendar
  • Earnings Transcripts
  • EDGAR Filing Screener
  • IPO Calendar
  • Compliance
  • Privacy
  • Security
  • Terms
AngelList LinkedIn